VanEck Biotech ETF BBH
Set alert
254.50 USD -3.48 -1.35%
At close · Nov 2
254.50 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
254.37 Day range 259.51
178.67 52-week range 257.98
- YTD
- +34.47%
- 1 year
- +40.50%
- Open
- 258.82
- Prev close
- 257.98
- Mkt cap
- 525.38M
- Vol
- 23.64K
- Avg vol
- 11.22K
- EPS
- 8.48
- P/E
- 30.01
- Div yield
- 0.00%
More statistics
- Low
- 254.37
- High
- 259.51
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 167.95
- 200-d avg
- 169.82
5D chart
Signals (38)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:30 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:30 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:45 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 3 days ago |
| RSI: Overbought | Oct 30, 9:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 9:30 AM | 3 days ago |
Newest 20 of 38.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 29.88
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 167.95
- 200-day average
- 169.82
About VanEck Biotech ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
- ETFs That You May Consider Amid a Strengthening Biotech Outlook
- Why Healthcare ETFs Are Hovering Around One-Year Highs
- Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy?
- Biotech ETF (BBH) Hits New 52-Week High
- BBH Capital Partners Private Equity Exits The Granite Group
- Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
- Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
- Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?
- Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
- Should You Invest in the VanEck Biotech ETF (BBH)?
Your note
Sign in to keep a note on BBH — it syncs with the Stock Master app.